THNR

$26.33

Fund Essentials - as of Oct 31, 2025

Net Assets
$3M
Expense Ratio
0.59%
Dividend Yield (Current)
-
Holdings
21
Inception Date
May 21, 2024
Fund Family
Amplify ETFs
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
NA

Performance

YTD+0.03%
1 Year+0.14%
3 Year+0.03%
5 Year+0.03%
10 Year+0.03%

Asset Allocation

Stocks: 99.02%
Cash: 0.98%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co.15.95%
NVO:CONovo-Nordisk A/S-Spons Adr Nomura10.46%
REGNRegeneron Pharmaceuticals, Inc.7.65%
AMGNAmgen Inc.7.48%
4519:JPChugai Pharmaceutical Ltd 7.27%
Top 10 Concentration: 73.87%Report Date: Oct 31, 2025

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This ETF
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more
1 Month
+3.08%
YTD
+14.12%
1 Year
+14.12%
3 Year
+3.17%

Top 10 Holdings (73.9% of portfolio)

#TickerNameSectorWeight
1LLYEli Lilly & Co.Health Care15.95%
2NVO:CONovo-Nordisk A/S-Spons Adr NomuraHealth Care10.46%
3REGNRegeneron Pharmaceuticals, Inc.Health Care7.65%
4AMGNAmgen Inc.Health Care7.48%
54519:JPChugai Pharmaceutical Ltd Unknown7.27%
6AZN:LNAstrazeneca Plc, AdrHealth Care5.17%
7MRKMerck & Co IncHealth Care5.14%
8ROG:SMRoche Holding AgUnknown5.03%
9ABBVAbbvie Inc.Health Care4.97%
10PFEPfizer, Inc.Health Care4.75%